.webp)
Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
These prices represent the manufacturer suggested retail before any discounts, negotiations, or insurance processing
The regulatory picture is unusual and worth stating plainly: the afamelanotide molecule is FDA-approved but only as SCENESSE, a 16 mg controlled-release bioresorbable implant placed by a trained clinician to reduce phototoxic pain in adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder [1]
Another effect of aging is capillary loss, accompanied by a decline in SIRT1 activity and NAD + levels
Pricing has become one of the biggest factors affecting future market growth
US$ 25.08
US$ 27.55
US$ 25.10
US$ 25.11
